




Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
A series of exercises and questions designed to reinforce understanding of key biostatistical concepts. It covers topics such as measures of central tendency, dispersion, incidence, prevalence, and study designs. The exercises are presented in a clear and concise manner, making them suitable for both university and high school students studying biostatistics or related fields.
Typology: Exams
1 / 8
This page cannot be seen from the preview
Don't miss anything!
Which |of |the |following |types |of |graphics |would |be |most |useful |in |demonstrating |the |frequency |of |a |given |outcome |as |it |relates |to |an |ordinal |variable? |- |correct |answer |✔histogram 5 | 7 | 6 | 9 | 4 | 1 | 2 | 2 According |to |the |data, |which |measure, |is |a |better |measure |of |dispersion? |- |correct |answer |✔standard |deviation Misclassification |bias |often |occurs |in |case-control |studies. |- |correct |answer |✔True The |incidence |rate |of |X |disease |in |patients |receiving |the |new |medication |is |calculated |by: |- |correct |answer |✔patients |who |are |receiving |the |new |medication |and |have |X |disease |/ |total |follow-up |(years) |of |the |patients |who |are |receiving |the |new |medication |( |times |(x) | 1000 |to |make |a |whole |number |if |necessary) |(a/b |if |set |up |in |correct |way) A |design |that |is |a |very |detailed |report |of |the |specific |features |of |a |particular |participant |or |case |is |known |as? |- |correct |answer |✔case |report The |Cumulative |incidence |is |computed |as |the |number |of |persons |who |develop |a |disease |during |a |specified |period |over |the |number |of |persons |examined |at |baseline |- |correct |answer |✔false
1,000 |people |are |enrolled |in |a |10-year |cohort |study. |At |the |start |of |the |study, | 100 |have |diagnosed |CVD. |Over |the |course |of |the |study, | 80 |people |who |were |free |of |CVD |at |baseline |develop |CVD. |What |is |the |cumulative |incidence |at | 10 |years? |- |correct |answer |✔0.089 |= |80/900: |the |number |of |new |events |or |cases |of |disease |divided |by |the |total |number |of |individuals |in |the |population |at |risk |for |a |specific |time |interval. Biostatistics |is |integral |to |the |field |of |epidemiology, |which |is |defined |as |study |of |health |and |illness |in |human |populations, |patterns |of |health |or |disease, |and |the |factors |that |influence |these |patterns. |- |correct |answer |✔True The |best |numerical |summaries |for |dichotomous, |ordinal, |and |categorical |variables |are |relative |frequencies. |- |correct |answer |✔true Incidence |of |disease |is |the |proportion |of |individuals |with |the |condition |(disease) |at |a |single |point |in |time |- |correct |answer |✔false The |following |data |were |collected |as |part |of |a |study |of |coffee |consumption |among |graduate |students. |The |following |reflect |cups |per |day |consumed: |3, |4, |6, | 8 |,2, |1, |0, |and |2. |The |standard |deviation |is |approximately |4. |- |correct |answer |✔false: |use |excel |to |find |stdev(). Assume |a |new |measure |of |Intelligence |Quotient |(or |IQ) |has |been |developed. |The |mean |IQ |for |the |population |is | 100 |and |the |standard |deviation |is |15. |The |standard |deviation |indicates |the |average |distance |an |individual |data |value |is |from |the |mean |is |about | 15 |IQ |points. |- |correct |answer |✔true
Which |type |of |study |design |can |assess |temporal |relationship? |- |correct |answer |✔a |cohort |study A |fungal |meningitis |outbreak |has |been |traced |back |to |a |particular |compound |pharmacy |selling |a |specific |injectable |drug |that |is |suspected |to |have |been |contaminated. |In |the |past | 4 |weeks |15,051 |patients |were |given |the |medication, |and |of |those |patients | 72 |individuals |contracted |fungal |meningitis. |What |is |the |cumulative |incidence |for |meningitis |among |those |individuals |who |the |medication |was |administered |to? |- |correct |answer |✔cumulative |incidence: |the |number |of |new |events |or |cases |of |disease |divided |by |the |total |number |of |individuals |in |the |population |at |risk |for |a |specific |time |interval. =72/15051 |=> |0.0048. Two |types |of |medical |devices |used |for |knee |replacement |are |being |studied |to |see |if |the |type |of |knee |replacement |used |affects |the |rate |of |infection |for |a |specific |bacterial |infection. |The |infection |rate |for |a |specific |bacterial |infection |after |surgery |for |device |A |is |0.0043. |The |rate |for |the |same |bacterial |infection |is |0.0121 |for |device |B. |How |does |the |risk |of |developing |the |bacterial |infection |in |individuals |using |device |B |compare |to |the |risk |of |developing |the |bacterial |infection |in |individuals |using |device |A? |- |correct |answer |✔Individuals |using |device |B |are |2.814 |(.0121/.0043) |times |more |likely |to |develop |the |bacterial |infection |of |interest |than |individuals |using |device |A. The |best |measure |of |central |tendency |for |systolic |blood |pressure |readings |obtained |from |a |population |of | 7 |individuals |whose |systolic |blood |pressure |readings |were |101, |104, |108, |109, |111, |112, |and | 160 |is |the |mean. |- |correct |answer |✔false
Understanding |biostatistical |principles |is |critical |to |public |health |education. |- |correct |answer |✔true The |following |data |were |collected |as |part |of |a |study |of |tea |consumption |among |undergraduate |students |in |England. |The |following |reflect |cups |per |day |consumed: 5 | 7 | 6 | 9 | 4 | 1 | 2 | 2 According |to |the |data |the |median |is: |- |correct |answer |✔4. The |mean |is |the |best |measure |of |typical |value |(central |tendency) |when |they |are |outliers |present |in |the |data. |- |correct |answer |✔false The |applicability |of |the |research |results |to |a |specific |population |obtained |from |a |biostatistics |study |is |best |determined |by |which |of |the |following? |- |correct |answer |✔The |inclusion |and |exclusion |criteria |of |the |study. Confounding |is |usually |a |major |issue |in |cohort |studies |- |correct |answer |✔True The |most |appropriate |study |design |depends, |among |other |things, |on |the |distribution |of |- |correct |answer |✔The |risk |factor |in |the |population |of |interest |& |The |outcome |in |the |population |of |interest What |is |the |incidence |rate |of |coronary |artery |disease |in |patients |receiving |placebo |approximately: | Info |given: |placebo |+ |coronary |artery |disease |= |28. |Total |follow-up |(years) |+ |placebo |= | 2750 |- |correct |answer |✔28/2750 |= |0.01018 |x | 1000 |=> | 10 |per | 1000 |person-years.
Odds |ratio |can |be |used |to |approximate |the |relative |risk |when |the |disease |under |study |is |rare. |- |correct |answer |✔true The |proportion |of |the |sample |with |disease |is |computed |by |taking |the |ratio |of |the |number |with |disease |to |the |total |sample |size. |- |correct |answer |✔true Calculate |the |lower |quartile |of |the |data |set |for |the |blood |glucose |levels |of | 10 |individuals |whose |blood |glucose |readings |were |as |follows: |88, |97, |101, |104, |104, |107, |109, |117, |121, |and |147. |- |correct |answer |✔101.0 |in |excel: |"=QUARTILE(A1:A10,1)" |or |for |third |quartile: |"=QUARTILE(A1:A10,3)" Risk |difference |may |sometimes |be |referred |to |as |excess |risk. |- |correct |answer |✔True Confounding |is |the |major |issue |in |clinical |trials. |- |correct |answer |✔false Two |thousand |are |enrolled |in |a |20-year |cohort |study. |At |the |start |of |the |study, |No |one |was |diagnosed |with |cardiovascular |disease. |Over |the |course |of |the |study, | 100 |people |who |were |free |of |cardiovascular |disease |at |baseline |develop |cardiovascular |disease. |The |prevalence |of |cardiovascular |disease |at |baseline |is |0. |- |correct |answer |✔True: |Prevalence |= |?the |proportion |of |persons |in |a |population |who |have |a |particular |disease |or |attribute |at |a |specified |point |in |time |or |over |a |specified |period |of |time.? What |is |the |ideal |study |design |from |a |statistical |point |of |view? |- |correct |answer |✔Clinical |trial
In |a |study |measuring |the |frequency |of |pain |scores |of |patients |on |a |scale |from | 1 |to | 10 |for |a |specific |type |of |pain |relief |therapy, |the |pain |score |variable |would |best |be |described |as |which |type |of |variable? |- |correct |answer |✔ordinal |variable Five |hundred |people |are |enrolled |in |a |10-year |cohort |study. |At |the |start |of |the |study, | 50 |have |diagnosed |CVD. |Over |the |course |of |the |study, | 40 |people |who |were |free |of |CVD |at |baseline |develop |CVD. |The |prevalence |of |CVD |at | 10 |years |is |10% |- |correct |answer |✔false Among |individuals |who |eat |a |healthy |diet |and |exercise |frequently |the |point |prevalence |of |hypertension |is |0.09. |Individuals |subject |to |poverty, |making |it |more |difficult |for |them |to |eat |a |healthy |diet |and |exercise |frequently, |have |a |0.31 |point |prevalence |for |hypertension. |What |is |the |risk |difference |between |the |two |groups? |- |correct |answer |✔.22: |risk |difference |= |difference |in |point |prevalence, |cumulative |incidence, |or |incidence |rates |(PP,ex |- |PP,unex |/ |CI,ex |- |CI,unex |/ |IR,ex |- |IR,unex) |= |.31 |- |.09 |= |. Race |is |an |example |of |which |type |of |variable? |- |correct |answer |✔categorical |variable Calculate |the |mean |blood |glucose |level |for |a |study |measuring |the |blood |glucose |levels |of | 10 |individuals |whose |blood |glucose |readings |were |as |follows: |88, |97, |101, |104, |104, |107, |109, |117, |121, |and |147. |- |correct |answer |✔109. Calculate |the |point |prevalence |for |Alzheimer's |disease |among |individuals | 65 |years |of |age |or |older |in |a |county |that |has |200,000 |individuals |who |are | 65 |years |of |age |or |older, |if |22,223 |individuals |who |are | 65 |years |of |age |or |older |have |the |disease. |- |correct |answer |✔.1111 |: |PP |= |# |of |ppl |with |disease |/ |# |of |ppl |examined |a |baseline: |22,223/200,000 |= |.